PH26303A - Stable pharmaceutical gel preparation - Google Patents

Stable pharmaceutical gel preparation Download PDF

Info

Publication number
PH26303A
PH26303A PH35716A PH35716A PH26303A PH 26303 A PH26303 A PH 26303A PH 35716 A PH35716 A PH 35716A PH 35716 A PH35716 A PH 35716A PH 26303 A PH26303 A PH 26303A
Authority
PH
Philippines
Prior art keywords
gel
compartment
package
compartments
components
Prior art date
Application number
PH35716A
Other languages
English (en)
Inventor
Michael Peter Ramsey
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PH26303A publication Critical patent/PH26303A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254Enzymes, proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH35716A 1986-08-22 1987-08-21 Stable pharmaceutical gel preparation PH26303A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8620425A GB2194144B (en) 1986-08-22 1986-08-22 Stable pharmaceutical gel preparation

Publications (1)

Publication Number Publication Date
PH26303A true PH26303A (en) 1992-04-29

Family

ID=10603089

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35716A PH26303A (en) 1986-08-22 1987-08-21 Stable pharmaceutical gel preparation

Country Status (11)

Country Link
EP (1) EP0264552A3 (ko)
JP (1) JPS6389160A (ko)
KR (1) KR880002503A (ko)
AU (1) AU599410B2 (ko)
DK (1) DK436987A (ko)
FI (1) FI873630A (ko)
GB (1) GB2194144B (ko)
NO (1) NO873534L (ko)
PH (1) PH26303A (ko)
PT (1) PT85544A (ko)
ZA (1) ZA876222B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA902066B (en) * 1989-04-14 1990-12-28 Minnesota Mining & Mfg Solid gel external drug delivery system
US6620436B1 (en) 1991-10-09 2003-09-16 Lectec Corporation Mixing and dispensing package for a wound dressing
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
EP0625894A1 (en) * 1991-10-09 1994-11-30 LecTec Corporation Aqueous gel wound dressing and package
DE4223004A1 (de) * 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
DE4435805A1 (de) * 1994-10-06 1996-04-11 Knoll Ag Zweikomponenten-Creme
DE19602208A1 (de) * 1996-01-23 1997-07-24 Nordmark Arzneimittel Gmbh In-situ gebildete Arzneiform zur Abgabe von Enzymen an Wunden
US5977428A (en) * 1996-12-20 1999-11-02 Procyte Corporation Absorbent hydrogel particles and use thereof in wound dressings
GB2328443B (en) 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8821473B2 (en) 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
EP1981473A4 (en) * 2006-02-06 2012-12-26 Taro Pharmaceuticals North America Inc PROTECTION-PROTECTED ANTIBIOTIC FORMULATIONS
US7732190B2 (en) 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
CN1944378A (zh) * 2006-10-23 2007-04-11 广东中科药物研究有限公司 一种联苯乙酸氨丁三醇盐及其制备方法
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8741326B2 (en) 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
FR3034016A1 (fr) * 2015-03-27 2016-09-30 Inst Nord Sud De Coop Biopharmaceutique Sachet pour la preparation d'une formulation pharmaceutique destinee a une administration orale, disposition comprenant un tel sachet et procedes de preparation associes
CN113197791B (zh) * 2021-04-26 2023-03-28 中山市粤美医疗生物科技有限公司 一种水润喷雾面膜及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB799069A (en) * 1956-04-24 1958-07-30 American Cyanamid Co Compositions for the reversal of inflamation in animals
US3608709A (en) * 1969-09-08 1971-09-28 Wayne Rogers V Multiple compartment package
US4276281A (en) * 1980-09-04 1981-06-30 Crikelair George F Burn treatment

Also Published As

Publication number Publication date
ZA876222B (en) 1988-02-23
NO873534L (no) 1988-02-23
GB2194144A (en) 1988-03-02
EP0264552A2 (en) 1988-04-27
FI873630A0 (fi) 1987-08-21
KR880002503A (ko) 1988-05-09
EP0264552A3 (en) 1989-01-18
DK436987D0 (da) 1987-08-21
PT85544A (pt) 1988-08-17
FI873630A (fi) 1988-02-23
GB8620425D0 (en) 1986-10-01
AU599410B2 (en) 1990-07-19
GB2194144B (en) 1990-04-25
DK436987A (da) 1988-02-23
NO873534D0 (no) 1987-08-21
JPS6389160A (ja) 1988-04-20
AU7729987A (en) 1988-02-25

Similar Documents

Publication Publication Date Title
AU599410B2 (en) Stable pharmaceutical gel preparation
EP0626844B1 (en) Compositions of clindamycin and benzoyl peroxide for acne treatment
RU2129862C1 (ru) Фармацевтическая композиция для наружного применения, способ обработки раны или другого состояния тела
JP3282817B2 (ja) マルチチャンバー容器
US6117843A (en) Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
EP0386960A2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
EP0114125A2 (en) Medication application systems
US20110004170A1 (en) Apparatus and Method for Reconstituting a Pharmaceutical and Preparing the Reconstituted Pharmaceutical for Transient Application
US5578310A (en) Topical bioadhesive ointment compositions and their use in wound healing
AU2002367086B2 (en) A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
JPH07500035A (ja) 水性ゲル傷用包帯剤およびパッケージ
HU226710B1 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
US7923431B2 (en) Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
EP0481600A2 (en) Materials useful in human and veterinary medicine
US9078822B2 (en) Dry liposomal PVP-iodine compositions
US20200289402A1 (en) Pouch-type orally dissolving films with high active ingredient concentration
JPH10500975A (ja) 乾燥剤を含有する注射用製剤
EP0589871B1 (en) Peritoneal induced medicaments
US20030203044A1 (en) Wound-treating gel
Wolf et al. Infectious sequelae in the use of polyglycolic acid mesh for splenic salvage with intraperitoneal contamination
US20240158596A1 (en) Systems and methods relating to medical applications of inverse thermosensitive polymer foam formulations
JPS5928533B2 (ja) 貼付剤
KR20220075907A (ko) 서로 다른 약제들을 동시에 배출할 수 있는 대장내시경 용 하제 제품
CA1230556A (en) Encapsulated antacid dispersions